Материалов:
1 005 012

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 1005012

Страница 1 из 100502

Recombinant interferon α-2b in the treatment of genital herpes: Clinical and laboratory rationale and efficacy evaluation. Objective. To conduct a comparative analysis of the efficacy of using recombinant interferon α-2b

Recombinant interferon-α2B efficacy in complex therapy of pneumonia in premature newbornsA prospective randomized study of clinical efficacy of recombinant interferon2b in combination

Interferon alpha-2b treatment for exophytic nasal papillomas and human papillomavirus infection with recombinant interferon and a reduction in the recurrence rate of ESP. Conclusion: According to the results

Recombinant interferon-a2b efficacy in complex therapy of pneumonia in premature newbornsA prospective randomized study of clinical efficacy of recombinant interferon-a2b in combination

Possibilities of recombinant interferon α-2b drugs in the complex therapy of mucosal candidiasis infection in patients at risk treatment tactics. Aim: this study aims to assess the impact of recombinant interferon a-2b combined

Different Kinds of Interferon-Corrective Therapy in Congenital and Acquired Interferonopathies is performed. In both replacement and interferon-corrective therapies recombinant human IFN alpha 2b VIFERON (R

The value of interferon therapy for COVID-19 in children in the immunopathogenesis of COVID-19 and the clinical efficacy of drugs based on recombinant interferon-alpha 2b

Controversial role of neutrophilic granulocytes in the immunopathogenesis of COVID-19: correlation with imbalance of pro-inflammatory neutrophil-associated cytokines and interferon alpha deficiency with an immunosuppressive and cytotoxic phenotype, exacerbating the course of COVID-19. The use of recombinant IFNα-2b

OBTAINING SINGLE DOMAIN NANOBODIES SPECIFIC FOR HUMAN INTERFERON-β AND THEIR USE IN AFFINITY PURIFICATION is paid to obtaining nanobodies specific for human interferon-β in order to obtain a preparation with high

Clinico-immunological effectiveness of immunotherapy in patients with respiratory syncytial virus infection (bronchitis, acute tonsillitis, pneumonia). 29 patients were treated by recombinant interferon2b in the form

Страница 1 из 100502